Rigel Pharmaceuticals Inc SEC filings RIGL
Rigel Pharmaceuticals Inc has 1,002 filings in SEC EDGAR's recent list, going back to Nov 6, 2007. Its latest annual report, Form 10-K, was filed on Mar 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Aug 9, 2024 | — |
| CORRESP | Letter to the SEC | Aug 8, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 7, 2024 | — |
| DEFR14A | Defr 14a | May 15, 2023 | — |
| EFFECT | Filing | May 3, 2022 | — |
| POSASR | Filing | Mar 1, 2022 | — |
| CT ORDER | Filing | Apr 24, 2020 | — |
| CT ORDER | Filing | Apr 24, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 18, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 5, 2020 | — |
| CT ORDER | Filing | Jan 16, 2020 | — |
| CT ORDER | Filing | Jan 16, 2020 | — |
| CT ORDER | Filing | Jan 16, 2020 | — |
| CT ORDER | Filing | Mar 20, 2019 | — |
| EFFECT | Filing | Apr 2, 2018 | — |
| CORRESP | Letter to the SEC | Apr 2, 2018 | — |
| UPLOAD | Letter from the SEC | Mar 19, 2018 | — |
| CT ORDER | Filing | Mar 15, 2018 | — |
| CT ORDER | Filing | Nov 18, 2016 | — |
| EFFECT | Filing | Jul 13, 2015 | — |
| CORRESP | Letter to the SEC | Jul 9, 2015 | — |
| CT ORDER | Filing | Jul 7, 2015 | — |
| CT ORDER | Filing | Jul 7, 2015 | — |
| UPLOAD | Letter from the SEC | May 14, 2015 | — |
| CT ORDER | Filing | Mar 18, 2015 | — |
| CT ORDER | Filing | Mar 18, 2015 | — |
| CT ORDER | Filing | Mar 18, 2015 | — |
| DEFR14A | Filing | Apr 4, 2013 | — |
| CT ORDER | Filing | Nov 2, 2012 | — |
| CT ORDER | Filing | Sep 11, 2012 | — |
| UPLOAD | Letter from the SEC | Aug 28, 2012 | — |
| CORRESP | Letter to the SEC | Aug 13, 2012 | — |
| UPLOAD | Letter from the SEC | Aug 7, 2012 | — |
| UPLOAD | Letter from the SEC | Apr 11, 2012 | — |
| CORRESP | Letter to the SEC | Apr 9, 2012 | — |
| UPLOAD | Letter from the SEC | Apr 6, 2012 | — |
| EFFECT | Filing | Mar 22, 2012 | — |
| CT ORDER | Filing | Aug 22, 2011 | — |
| EFFECT | Filing | Jan 7, 2011 | — |
| CORRESP | Letter to the SEC | Jan 5, 2011 | — |
| UPLOAD | Letter from the SEC | Dec 28, 2010 | — |
| CORRESP | Letter to the SEC | Dec 22, 2010 | — |
| UPLOAD | Letter from the SEC | Dec 20, 2010 | — |
| UPLOAD | Letter from the SEC | Dec 16, 2010 | — |
| CT ORDER | Filing | Jun 22, 2010 | — |
| CT ORDER | Filing | Feb 25, 2010 | — |
| CT ORDER | Filing | Feb 25, 2010 | — |
| CT ORDER | Filing | Feb 25, 2010 | — |
| UPLOAD | Letter from the SEC | Jan 4, 2010 | — |
| CORRESP | Letter to the SEC | Dec 4, 2009 | — |
| CORRESP | Letter to the SEC | Nov 12, 2009 | — |
| UPLOAD | Letter from the SEC | Oct 30, 2009 | — |
| CORRESP | Letter to the SEC | Oct 5, 2009 | — |
| UPLOAD | Letter from the SEC | Sep 21, 2009 | — |
| EFFECT | Filing | Apr 30, 2009 | — |
| CORRESP | Letter to the SEC | Apr 28, 2009 | — |
| UPLOAD | Letter from the SEC | Mar 11, 2009 | — |
| POSASR | Filing | Feb 26, 2009 | — |
Showing 58 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RIGL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1034842
- Former names
- RIGEL PHARMACEUTICALS INC (until Nov 5, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.